Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 14, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$33.4B
sum of reported positions
Reported positions
455
Changes vs prior quarter
466
80 new · 85 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 297 measured positions in 8 quarters, the typical new or larger position finished −2.7 pts against the S&P 500 and 43% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 8.01M | $1.6B | 4.8% | |
| 3.72M | $1.33B | 4.0% | |
| 1.55M | $673M | 2.0% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.

Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $29.2B | $33.4B |
| Positions | 460 | 455 |
| Biggest line | — | NVIDIA 5% |
| 1.68M |
| $635M |
| 1.9% |
| 1.23M | $589M | 1.8% |
| 1.58M | $517M | 1.5% |
| 428K | $513M | 1.5% |
| 1.59M | $460M | 1.4% |
| 1.23M | $457M | 1.4% |
| 2.14M | $447M | 1.3% |
| 209K | $415M | 1.2% |
| 977K | $406M | 1.2% |
| 1.01M | $402M | 1.2% |
| 388K | $379M | 1.1% |
| 1.48M | $375M | 1.1% |
| 1.71M | $302M | 0.9% |
| 254K | $293M | 0.9% |
| 1.22M | $280M | 0.8% |
| 2.44M | $280M | 0.8% |
| 1.81M | $272M | 0.8% |
| 440K | $271M | 0.8% |
| 715K | $267M | 0.8% |
| 4.65M | $265M | 0.8% |
| 315K | $262M | 0.8% |
| 1.76M | $256M | 0.8% |
Dianthus Therapeutics, Inc. (DNTH)
299K → 422K shares (+41%)
Tesla (TSLA)
241K → 97K shares (−60%)
Hut 8 (HUT)
241K → 347K shares (+44%)
Ascendis Pharma A (ASND)
144K shares
Applied Digital (APLD)
1.18M → 1.02M shares (−14%)
Hinge Health (HNGE)
93K → 452K shares (+389%)
Bridgebio Pharma (BBIO)
1.02M → 500K shares (−51%)
Miami International Holdings (MIAX)
861K → 1M shares (+16%)
Tpg (TPG)
697K → 916K shares (+31%)
Oruka Therapeutics (ORKA)
390K shares
Celcuity (CELC)
439K → 352K shares (−20%)
Saia (SAIA)
34K → 86K shares (+158%)
Lindblad Expeditions Holdings (LIND)
525K → 1.27M shares (+142%)
CDW Corporation (CDW)
255K shares
Brady Corporation (BRC)
355K → 390K shares (+10%)
Coca-Cola Consolidated (COKE)
229K → 184K shares (−20%)
Space Exploration Technologies (SPCX)
200K shares
Palantir (PLTR)
1.19M → 290K shares (−76%)
Teledyne Technologies (TDY)
41K → 50K shares (+22%)
Assurant (AIZ)
121K → 119K shares (−1%)
Moog Inc. (MOG.A)
74K shares
Curtiss-Wright (CW)
44K → 41K shares (−7%)
Twist Bioscience (TWST)
100K → 299K shares (+200%)
Generac (GNRC)
150K → 105K shares (−30%)
Lincoln Educational Services (LINC)
623K → 615K shares (−1%)